236 related articles for article (PubMed ID: 27823573)
1. The Sphingosine 1-Phosphate Signaling Pathway in Epilepsy: A Possible Role for the Immunomodulator Drug Fingolimod in Epilepsy Treatment.
Leo A; Citraro R; Marra R; Palma E; Paola EDD; Constanti A; De Sarro G; Russo E
CNS Neurol Disord Drug Targets; 2017; 16(3):311-325. PubMed ID: 27823573
[TBL] [Abstract][Full Text] [Related]
2. To fingolimod and beyond: The rich pipeline of drug candidates that target S1P signaling.
Chew WS; Wang W; Herr DR
Pharmacol Res; 2016 Nov; 113(Pt A):521-532. PubMed ID: 27663260
[TBL] [Abstract][Full Text] [Related]
3. Sphingosine-1-Phosphate (S1P) and S1P Signaling Pathway: Therapeutic Targets in Autoimmunity and Inflammation.
Tsai HC; Han MH
Drugs; 2016 Jul; 76(11):1067-79. PubMed ID: 27318702
[TBL] [Abstract][Full Text] [Related]
4. Second generation S1P pathway modulators: research strategies and clinical developments.
Bigaud M; Guerini D; Billich A; Bassilana F; Brinkmann V
Biochim Biophys Acta; 2014 May; 1841(5):745-58. PubMed ID: 24239768
[TBL] [Abstract][Full Text] [Related]
5. Neuropsychiatric Systemic Lupus Erythematosus Is Dependent on Sphingosine-1-Phosphate Signaling.
Mike EV; Makinde HM; Der E; Stock A; Gulinello M; Gadhvi GT; Winter DR; Cuda CM; Putterman C
Front Immunol; 2018; 9():2189. PubMed ID: 30319641
[TBL] [Abstract][Full Text] [Related]
6. Sphingosine 1-phosphate signaling at the blood-brain barrier.
Prager B; Spampinato SF; Ransohoff RM
Trends Mol Med; 2015 Jun; 21(6):354-63. PubMed ID: 25939882
[TBL] [Abstract][Full Text] [Related]
7. Role of the S1P pathway and inhibition by fingolimod in preventing hemorrhagic transformation after stroke.
Salas-Perdomo A; Miró-Mur F; Gallizioli M; Brait VH; Justicia C; Meissner A; Urra X; Chamorro A; Planas AM
Sci Rep; 2019 Jun; 9(1):8309. PubMed ID: 31165772
[TBL] [Abstract][Full Text] [Related]
8. Sphingosine 1 Phosphate at the Blood Brain Barrier: Can the Modulation of S1P Receptor 1 Influence the Response of Endothelial Cells and Astrocytes to Inflammatory Stimuli?
Spampinato SF; Obermeier B; Cotleur A; Love A; Takeshita Y; Sano Y; Kanda T; Ransohoff RM
PLoS One; 2015; 10(7):e0133392. PubMed ID: 26197437
[TBL] [Abstract][Full Text] [Related]
9. Evaluation and Optimization of
Gusman DH; Shoemake C
Yale J Biol Med; 2017 Mar; 90(1):15-23. PubMed ID: 28356890
[TBL] [Abstract][Full Text] [Related]
10. [Sphingosine-1-phosphate signaling system and the innovative mechanism of action of fingolimod in treatment of multiple sclerosis: review of foreign literature].
Shmyrev VI; Kryzhanovskiĭ SM; Danilycheva IV
Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(2 Pt 2):93-7. PubMed ID: 22677684
[TBL] [Abstract][Full Text] [Related]
11. Beneficial Effects of Fingolimod in Alzheimer's Disease: Molecular Mechanisms and Therapeutic Potential.
Angelopoulou E; Piperi C
Neuromolecular Med; 2019 Sep; 21(3):227-238. PubMed ID: 31313064
[TBL] [Abstract][Full Text] [Related]
12. The neurobiology of sphingosine 1-phosphate signaling and sphingosine 1-phosphate receptor modulators.
Soliven B; Miron V; Chun J
Neurology; 2011 Feb; 76(8 Suppl 3):S9-14. PubMed ID: 21339490
[TBL] [Abstract][Full Text] [Related]
13. [Effects of sphingosine 1-phosphate on functions of T cell - review].
Huang WR; Wang LS; DA WM
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Aug; 13(4):718-22. PubMed ID: 16129068
[TBL] [Abstract][Full Text] [Related]
14. Sphingosine-1-phosphate modulators in inflammatory skin diseases - lining up for clinical translation.
Thieme M; Zillikens D; Sadik CD
Exp Dermatol; 2017 Mar; 26(3):206-210. PubMed ID: 27574180
[TBL] [Abstract][Full Text] [Related]
15. Fingolimod promotes peripheral nerve regeneration via modulation of lysophospholipid signaling.
Szepanowski F; Derksen A; Steiner I; Meyer Zu Hörste G; Daldrup T; Hartung HP; Kieseier BC
J Neuroinflammation; 2016 Jun; 13(1):143. PubMed ID: 27283020
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms of fingolimod's efficacy and adverse effects in multiple sclerosis.
Cohen JA; Chun J
Ann Neurol; 2011 May; 69(5):759-77. PubMed ID: 21520239
[TBL] [Abstract][Full Text] [Related]
17. Sphingosine 1-phosphate signaling impacts lymphocyte migration, inflammation and infection.
Tiper IV; East JE; Subrahmanyam PB; Webb TJ
Pathog Dis; 2016 Aug; 74(6):. PubMed ID: 27354294
[TBL] [Abstract][Full Text] [Related]
18. Integrated sphingosine-1 phosphate signaling in the central nervous system: From physiological equilibrium to pathological damage.
Ghasemi R; Dargahi L; Ahmadiani A
Pharmacol Res; 2016 Feb; 104():156-64. PubMed ID: 26772814
[TBL] [Abstract][Full Text] [Related]
19. Clinical immunology of the sphingosine 1-phosphate receptor modulator fingolimod (FTY720) in multiple sclerosis.
Mehling M; Johnson TA; Antel J; Kappos L; Bar-Or A
Neurology; 2011 Feb; 76(8 Suppl 3):S20-7. PubMed ID: 21339487
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic Potential of the Modulation of Sphingosine-1-Phosphate Receptors.
Delgado A; Martínez-Cartro M
Curr Med Chem; 2016; 23(3):242-64. PubMed ID: 26639095
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
